ConductScience.org, home

Paper21079040

Prevention or modification of epileptogenesis after brain insults: experimental approaches and translational research.

Löscher W and 1 other. Pharmacol Rev, 2010. Cited by 322 papers, by iCite.

Cite this record

ConductScience Library. Prevention or modification of epileptogenesis after brain insults: experimental approaches and translational research. Papers, record 21079040. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21079040

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Prevention or modification of epileptogenesis after brain insults: experimental approaches and translational research.
PubMed
Journal
Pharmacol Rev
PubMed
Year
2010
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
322
iCite
Relative citation ratio, by iCite
10.2
iCite
Revised in PubMed
2025-03-20
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Löscher WWolfgang
2Brandt CClaudia

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AnticonvulsantsMajor topic
EpilepsyMajor topic
Animals
Brain Injuries
Disease Models, Animal
Humans
Stroke
Translational Research, Biomedical

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R21 NS049592NINDS NIH HHSUnited StatesR21NS049592PubMed and NIH
R21-NS049592NINDS NIH HHSUnited StatesR21NS049592PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References245

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112428028Epilepsy after brain insult: targeting epileptogenesis.Neurology2002https://conductscience.org/library/papers/12428028PubMed
217029741Effect of levetiracetam on visual-spatial memory following status epilepticus.Epilepsy Res2007https://conductscience.org/library/papers/17029741PubMed
318070091Early treatment suppresses the development of spike-wave epilepsy in a rat model.Epilepsia2008https://conductscience.org/library/papers/18070091PubMed
412399072Effect of topiramate following recurrent and prolonged seizures during early development.Epilepsy Res2002https://conductscience.org/library/papers/12399072PubMed
514584819The recurrent mossy fiber pathway of the epileptic brain.Neurochem Res2003https://conductscience.org/library/papers/14584819PubMed
620573906Disease-modifying effects of phenobarbital and the NKCC1 inhibitor bumetanide in the pilocarpine model of temporal lobe epilepsy.J Neurosci2010https://conductscience.org/library/papers/20573906PubMed
718389497Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex.Ann Neurol2008https://conductscience.org/library/papers/18389497PubMed
89108112Genetic determinants of susceptibility to excitotoxic cell death: implications for gene targeting approaches.Proc Natl Acad Sci U S A1997https://conductscience.org/library/papers/9108112PubMed
916709666Anomalous levels of Cl- transporters in the hippocampal subiculum from temporal lobe epilepsy patients make GABA excitatory.Proc Natl Acad Sci U S A2006https://conductscience.org/library/papers/16709666PubMed
109865538Hippocampal sclerosis revisited.Brain Dev1998https://conductscience.org/library/papers/9865538PubMed
1118590620New molecular targets for antiepileptic drugs: alpha(2)delta, SV2A, and K(v)7/KCNQ/M potassium channels.Curr Neurol Neurosci Rep2008https://conductscience.org/library/papers/18590620PubMed
1215571506Striking differences in individual anticonvulsant response to phenobarbital in rats with spontaneous seizures after status epilepticus.Epilepsia2004https://conductscience.org/library/papers/15571506PubMed
1318330004Neuroprotection in epilepsy.Epilepsia2007https://conductscience.org/library/papers/18330004PubMed
1416439585Treatment of experimental status epilepticus in immature rats: dissociation between anticonvulsant and antiepileptogenic effects.Pediatr Res2006https://conductscience.org/library/papers/16439585PubMed
1512183340Disease modification in partial epilepsy.Brain2002https://conductscience.org/library/papers/12183340PubMed
1610768292An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action.Epilepsia2000https://conductscience.org/library/papers/10768292PubMed
1717571349Epileptogenesis in experimental models.Epilepsia2007https://conductscience.org/library/papers/17571349PubMed
1817521347The antiepileptic drug levetiracetam stabilizes the human epileptic GABAA receptors upon repetitive activation.Epilepsia2007https://conductscience.org/library/papers/17521347PubMed
1914568348Changes in chloride homeostasis-regulating gene expressions in the rat hippocampus following amygdala kindling.Brain Res2003https://conductscience.org/library/papers/14568348PubMed
202289478The effect of interstimulation interval on the assessment of anticonvulsant drug potency in fully kindled rats.Epilepsy Res1990https://conductscience.org/library/papers/2289478PubMed

See all 245 referencesDownload CSV of references

Cited by167

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 322 citations.

PMIDTitleJournalYearIn PapersSource
42939870CDDO-EA Attenuates Acute Seizures and Suppresses Post-Status Epilepticus Epileptogenesis.Antioxidants (Basel)2026https://conductscience.org/library/papers/42939870PubMed
42794755Advancing the Paradigm of Temporal Lobe Epilepsy as a Network Disease: The Promise of Biomarkers and Targeted Disease Modification.Int J Mol Sci2026https://conductscience.org/library/papers/42794755PubMed
42794466GLP-1 Receptor Agonists in Epilepsy: Separating Evidence for Antiseizure Activity, Neuroprotection, and Disease Modification.Int J Mol Sci2026https://conductscience.org/library/papers/42794466PubMed
42651840Selected Molecular Targets for Counteracting Epileptogenesis: What Do We Know About Its Effective Inhibition?Curr Issues Mol Biol2026https://conductscience.org/library/papers/42651840PubMed
42357670Human Herpesvirus-6A and -6B (HHV-6A and HHV-6B): The Role of Roseoloviruses in Neurological Dysfunction and the Mechanisms of Viral-Induced Epileptogenesis.Viruses2026https://conductscience.org/library/papers/42357670PubMed
42017361A consensus roadmap for post-traumatic epilepsy: Clinical biomarkers, research priorities, policy barriers, and pathways to interventional trials.Epilepsia2026https://conductscience.org/library/papers/42017361PubMed
41997955Perirhinal cortex gains control of hippocampal seizures via broad downstream circuits in male mouse models.Nat Commun2026https://conductscience.org/library/papers/41997955PubMed
41915362The Complexity and Challenges of Developing Effective Epilepsy Therapies: Lessons to be Learned from Comparing Cenobamate, Carisbamate, and Padsevonil.CNS Drugs2026https://conductscience.org/library/papers/41915362PubMed
41591075The Role of Blood-Brain Barrier Disruption in Epilepsy: Mechanisms and Consequences.Neurol Int2025https://conductscience.org/library/papers/41591075PubMed
41320877Diverse species of animal models in epilepsy research: Progress and perspectives.Zool Res2025https://conductscience.org/library/papers/41320877PubMed
41096582Organophosphate Chemical Nerve Agents, Oxidative Stress, and NADPH Oxidase Inhibitors: An Overview.Int J Mol Sci2025https://conductscience.org/library/papers/41096582PubMed
41045366Brivaracetam and Topiramate Co-Therapy Attenuates Seizure Progression, Neuroinflammation, and Hippocampal Pathology in Chronic Pentylenetetrazole-Kindled Mice.Neurochem Res2025https://conductscience.org/library/papers/41045366PubMed
40839114Modulation of epileptogenesis through transplantation of human mesenchymal stem cells with or without GDNF release.Cell Mol Life Sci2025https://conductscience.org/library/papers/40839114PubMed
40430067Reversing Epigenetic Dysregulation in Neurodegenerative Diseases: Mechanistic and Therapeutic Considerations.Int J Mol Sci2025https://conductscience.org/library/papers/40430067PubMed
40430045Distribution of NECAB1-Positive Neurons in Normal and Epileptic Brain-Expression Changes in Temporal Lobe Epilepsy and Modulation by Levetiracetam and Brivaracetam.Int J Mol Sci2025https://conductscience.org/library/papers/40430045PubMed
40296431Calpastatin, a calpain specific inhibitor, reduce seizures in a mouse model of temporal lobe epilepsy.Epilepsia Open2025https://conductscience.org/library/papers/40296431PubMed
40285834Anticonvulsant effects of noscapine against status epilepticus induced by lithium-pilocarpine in rats: involvement of Nrf2/HO-1 and NLRP3 pathways.Naunyn Schmiedebergs Arch Pharmacol2025https://conductscience.org/library/papers/40285834PubMed
40262903High-Order Information Analysis of Epileptogenesis in the Pilocarpine Rat Model of Temporal Lobe Epilepsy.eNeuro2025https://conductscience.org/library/papers/40262903PubMed
40228896Mitochondrial Glutamine Metabolism Drives Epileptogenesis in Primary Hippocampal Neurons.J Neurosci2025https://conductscience.org/library/papers/40228896PubMed
40207615Voxel-Based Lesion Symptom Mapping to Predict Poststroke Epilepsy After Mechanical Thrombectomy.Eur J Neurol2025https://conductscience.org/library/papers/40207615PubMed

See all 167 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/21079040

GET https://conductscience.org/api/papers/v1/21079040/references?page=2